Why physiotherapy comes before anything else

Your consultant has referred you for six weeks of physiotherapy before discussing injections or surgery — and that sequence is deliberate, not a delay tactic.

NICE guideline NG226 (2022) designates structured exercise as the mandatory first-line treatment for knee osteoarthritis in everyone aged 16 and over. The NHS follows the same position: exercise that builds muscle and strengthens the joint is recommended as the core intervention before any further step on the treatment ladder is considered. Crucially, this is not a gatekeeping formality. OARSI and EULAR — the two principal international bodies for musculoskeletal disease — carry identical recommendations, supported by level 1a evidence drawn from meta-analyses of randomised controlled trials. That places physiotherapy at the top of the evidence hierarchy, not at the bottom of a waiting list.

Physiotherapy at this stage is not a placeholder while 'real' treatment is arranged. It is the treatment with the strongest evidence base available at the early-to-moderate stage of knee OA. Six weeks is the established clinical threshold at which meaningful gains in pain and function are expected, and at which a specialist can properly assess whether further intervention is warranted.

What knee cartilage actually needs to survive

Cartilage is unlike almost every other tissue in the body. The hyaline articular cartilage lining your knee joint contains no blood vessels and no nerves — which is why cartilage damage often goes unfelt until it is well advanced, and why the tissue cannot simply draw on a local blood supply to sustain itself.

Instead, cartilage depends entirely on synovial fluid for its nutrients and for the removal of metabolic waste. That fluid does not circulate passively: it is driven in and out of the cartilage matrix — through its glycosaminoglycans and proteoglycans — by the mechanical pressure of loading. Each time weight passes through the joint, cartilage is gently compressed; when the load lifts, fluid is drawn back in, carrying oxygen and nutrients with it. Movement is, in a literal sense, the nutrient delivery system.

The corollary matters just as much. Prolonged immobilisation causes measurable cartilage degradation — the matrix breaks down not through overuse but through the absence of the loading cycle that keeps it supplied. Choosing rest over movement is not a protective strategy for the cartilage; it removes the mechanism the tissue depends on to stay intact.

This is why physiotherapy's first cartilage role is preventive. Before any question of strengthening or load redistribution arises, structured movement maintains the nutritional environment that cartilage already requires to survive.

The dominant mechanism: rebuilding quadriceps control

The single most consistent finding in knee osteoarthritis is not cartilage loss — it is quadriceps weakness. Reduced strength in the quadriceps, and particularly in the vastus medialis oblique (VMO), is both a consequence of living with a painful knee and an independent driver of its deterioration. When the quadriceps fail to absorb compressive forces efficiently, those forces are transferred directly onto the medial tibial cartilage — the most commonly affected surface in knee OA. The tissue ends up carrying shock it was never designed to bear alone.

A six-week progressive strengthening programme works by reversing that pattern. Improved quadriceps activation — measurable within weeks of consistent loading — redistributes compressive force more evenly across the joint surface, reducing the localised stress that drives cartilage breakdown. This is the load-redistribution mechanism at the centre of the physiotherapy programme: the muscle acts as a shock absorber, and the aim is to restore its capacity to do so.

In patients managing excess weight, the arithmetic becomes particularly compelling. Evidence suggests that each kilogram of body weight lost corresponds to approximately a 4 kg reduction in peak compressive force through the knee during walking — a multiplier effect that compounds the gains from strengthening alone.

Low-impact aerobic conditioning — cycling, swimming, and elliptical training — completes the picture. These modalities support synovial fluid circulation and cardiovascular conditioning without generating the high peak loads that can exceed cartilage tolerance, making them a practical adjunct rather than a competing priority.

What is happening at the cartilage matrix level

Beneath the mechanical gains described above, something quieter is happening at the level of the cartilage matrix itself.

The matrix — built from glycosaminoglycans, proteoglycans, and collagen fibres — responds to appropriate cyclical loading by increasing proteoglycan synthesis. This is a metabolic signal, not a structural rebuild: the tissue is ramping up the molecular machinery that maintains its architecture and its water-binding capacity. Six weeks of physiotherapy is most accurately framed as establishing the right mechanical and nutritional conditions for that process, rather than as cartilage restoration in any direct sense.

These biochemical changes occur before any morphological difference would appear on a standard MRI scan. Detecting them requires advanced compositional MRI — techniques capable of mapping glycosaminoglycan concentration and collagen organisation at the molecular level — rather than the conventional imaging most patients receive. Cartilage biomarkers such as COMP and urinary CTX-II provide a complementary indirect signal that exercise is modulating cartilage metabolism, though direct structural repair within six weeks is not established by the current evidence.

A standard MRI showing no change in cartilage thickness after a six-week programme is not evidence the programme has failed; it reflects the resolution limits of conventional scanning, not the absence of a biochemical response. The meaningful gains at this stage are metabolic and mechanical — and both are real, even when a scan cannot yet show them.

What actually improves in six weeks — and what takes longer

Most patients notice the first gains not on a questionnaire but on the stairs — morning stiffness that previously lasted an hour begins to shorten, and walking distances that felt uncertain become routine again. These are the early functional markers clinicians track, and they correspond to real, measurable improvements in validated outcome scores. Six weeks of structured physiotherapy consistently produces moderate-effect-size improvements in pain and self-reported function on WOMAC and VAS scales — the same measures used in clinical trials to determine whether a treatment is working.

What drives these gains is neuromuscular adaptation and improved synovial circulation. That distinction matters mainly because it calibrates expectations: progress at six weeks is genuine, but it registers in what patients can do — not in what a standard scan can show.

Patients who do not feel dramatically better at six weeks have not exhausted physiotherapy as an option. Pain response varies considerably between individuals, and a programme that has not fully landed is more likely to need adjustment — in exercise selection, loading progression, or adjunct support — than to be abandoned. The evidence does not support interpreting modest early gains as treatment failure.

Clinically, six weeks marks a structured review point on the treatment pathway. NICE NG226 positions it as the moment the consultant reassesses whether conservative management is delivering sufficient benefit and whether the next step on the treatment ladder is warranted.

When six weeks is not enough: the next step in the pathway

Six weeks marks a decision point, not a deadline. For patients whose symptoms have not improved sufficiently by that review, specialist assessment is the appropriate next step — not resignation to chronic pain.

That assessment addresses two questions together: whether the programme itself was adequate — progressive loading, supervised technique, consistent attendance — and what the full clinical picture reveals about the underlying joint state. Imaging at this stage is one input, best read alongside symptoms and functional testing rather than as a standalone verdict.

Where conservative management has delivered partial but insufficient benefit, the treatment ladder moves to injection therapies — corticosteroid, hyaluronic acid, or biologic options such as PRP — and, where indicated, to cartilage-preservation assessment or a surgical discussion. NICE NG226 positions these options as sequential, not interchangeable; the right choice depends on OA grade, symptom pattern, and individual goals.

The team at London Cartilage Clinic on Harley Street offers specialist assessment at this juncture, available via londoncartilage.com.

Patients who reach that assessment having completed a structured physiotherapy programme arrive in the stronger position: the joint environment — load distribution, synovial circulation, neuromuscular control — has already been optimised, and that foundation improves the conditions for whatever intervention follows. The pathway builds on itself; conservative care is not the stage before treatment begins — it is the stage that makes subsequent treatment work.

1. [1] Osteoarthritis. https://en.wikipedia.org/?curid=504841 https://en.wikipedia.org/?curid=504841
2. [2] Hyaline cartilage. https://en.wikipedia.org/?curid=1130627 https://en.wikipedia.org/?curid=1130627
3. [3] Cartilage. https://en.wikipedia.org/?curid=166945 https://en.wikipedia.org/?curid=166945
4. [4] Articular cartilage damage. https://en.wikipedia.org/?curid=19057920 https://en.wikipedia.org/?curid=19057920